PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
21-Apr-2020 Sartorius Off to a Dynamic Start in Fiscal 2020 Sartorius AG
21-Apr-2020 Sartorius Stedim Biotech With a Strong Start in 2020 Sartorius Stedim Biotech S.A.
20-Apr-2020 Correction of a release from 20/04/2020, 22:53 CET/CEST - Drägerwerk AG & Co. KGaA: Dräger sets placement price of new preference shares and raises EUR 76.5 million in gross proceeds and terminates series A and K participation certificates Drägerwerk AG & Co. KGaA
20-Apr-2020 Drägerwerk AG & Co. KGaA: Dräger sets placement price of new preference shares and raises EUR 76.5 million in gross proceeds and terminates series A and K participation certificates Drägerwerk AG & Co. KGaA
20-Apr-2020 4basebio AG: 4basebio AG resolves on capital reduction by way of redemption of approx. 5.2 million treasury shares in accordance with the authorizing resolution of the general meeting 4basebio AG
20-Apr-2020 4D pharma announces expedited UK regulatory acceptance to commence Phase II study in COVID-19 4D pharma
20-Apr-2020 HumanOptics AG: Dr. Pierre Billardon leaves the Management Board on 30 April 2020; Diana Bachmann appointed as his successor HumanOptics AG
20-Apr-2020 Drägerwerk AG & Co. KGaA: Dräger resolves capital increase of preferred shares (ISIN: DE0005550636) against cash contributions from authorized capital Drägerwerk AG & Co. KGaA
20-Apr-2020 Biofrontera AG: Biofrontera Reports Full Year 2019 Financial Results Biofrontera AG
20-Apr-2020 Transcenta Received IND Clearance from FDA for Initiating Clinical Trials for its Novel Humanized Claudin 18.2 Monoclonal Antibody TST001 Transcenta
20-Apr-2020 Solentim and ATUM to bundle Leap-In Transposase® with the VIPS™ single cell cloning instrument for cell line development Sciad Newswire
20-Apr-2020 Registration Opens for SMi's Inaugural Aseptic Processing Conference SMi Group
20-Apr-2020 Precigen Announces Clearance of IND to Initiate Phase I/II Study for First-in-Class PRGN-2009 AdenoVerse(TM) Immunotherapy to Treat HPV-positive (HPV+) Solid Tumors Precigen, Inc.
20-Apr-2020 COVID-19 Update: Highly Potent Active Pharmaceutical Ingredients 2020 now Remote Access only SMi Group
20-Apr-2020 Biofrontera AG: Biofrontera AG enters into exclusive license agreement with Maruho Co., Ltd. Biofrontera AG
20-Apr-2020 MicrofluidX raises £1.4m in seed funding to develop novel cell therapy bioprocessing technology Sciad Newswire
20-Apr-2020 Zur Rose Group AG publishes adjusted proposal for the creation of authorized share capital and withdraws the agenda item relating to the creation of additional conditional capital for the Annual General Meeting 2020 Zur Rose Group AG
19-Apr-2020 Asklepios rejects demands by B. Braun and announces its intention to demand the convocation of an extraordinary general shareholders' meeting to remove and elect members of the Supervisory Board RHÖN-KLINIKUM Aktiengesellschaft
19-Apr-2020 Fosun Pharma Receives FDA Emergency Use Authorization (EUA) For Its COVID-19 RT-PCR Detection Kit Fosun Pharma
18-Apr-2020 Coronavirus (COVID-19) Update: Serological Test Validation and Education Efforts U.S. Food and Drug Administration